The use of dextranomer in decubitus ulcers: a histopathologic evaluation.
The decubitus ulcers of 4 patients being treated with dextranomer for up to three months were examined. Histopathologic sections showed only a minimal inflammatory response and no irritation. Dextranomer may be used for long periods without any tissue damage.
D003911:Dextrans / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D003668:Pressure Ulcer / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology
D003911:Dextrans; C013471:dextranomer